Literature DB >> 16766374

Influenza vaccination and the production of anti-phospholipid antibodies in patients with systemic lupus erythematosus.

P Tarján, S Sipka, G Lakos, E Kiss, G Ujj, G Szegedi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16766374     DOI： 10.1080/03009740500474552

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN： 0300-9742            Impact factor:   3.641


× No keyword cloud information.
  5 in total

1.  Influenza vaccination can induce new-onset anticardiolipins but not β2-glycoprotein-I antibodies among patients with systemic lupus erythematosus.

Authors:  E S Vista; S R Crowe; L F Thompson; G M Air; J M Robertson; J M Guthridge; J A James
Journal:  Lupus       Date:  2012-02       Impact factor: 2.911

Review 2.  Antiphospholipid antibodies in response to infection.

Authors:  Tadej Avcin; Natasa Toplak
Journal:  Curr Rheumatol Rep       Date:  2007-06       Impact factor: 4.686

Review 3.  Is Systemic Lupus Erythematosus Associated With a Declined Immunogenicity and Poor Safety of Influenza Vaccination?: A Systematic Review and Meta-Analysis.

Authors:  Yafang Huang; Huili Wang; Ling Wan; Xiaoqin Lu; Wilson W S Tam
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

Review 4.  Environmental Triggers of Autoreactive Responses: Induction of Antiphospholipid Antibody Formation.

Authors:  Anush Martirosyan; Rustam Aminov; Gayane Manukyan
Journal:  Front Immunol       Date:  2019-07-10       Impact factor: 7.561

Review 5.  Vaccines, adjuvants and autoimmunity.

Authors:  Luísa Eça Guimarães; Britain Baker; Carlo Perricone; Yehuda Shoenfeld
Journal:  Pharmacol Res       Date:  2015-08-12       Impact factor: 7.658
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.